Integrated Annual Report

Overview

The report presents Aurobindo Pharma's FY24 integrated financial and sustainability performance, including consolidated revenue of ₹290,018.7 million. The company reports 14% renewable power utilisation, a ~16% carbon-emission reduction and ~2,32,373 KL of treated wastewater reused. Its workforce comprised 26,015 employees and 11,581 workers, with women representing 12.54% of the workforce. The BRSR Core sustainability information received reasonable assurance from Sharp & Tannan Associates.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 April 2023 – 31 March 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services